Tenderwize
Back to tender search

Open-House-Biologika-Rabattverträge 2025-17 - Agalsidase beta

Techniker Krankenkasse·Hamburg, Germany·Deadline Jun 29, 2027 · 314 days left·Open·Supplies
Sign up to saveOpen documents
Structured notice only
Original notice title

Germany – Pharmaceutical products – Open-House-Biologika-Rabattverträge 2025-17 -Agalsidase beta

40/100

Opportunity Score

Needs reviewLow complexity
SuppliesOpen
Why this score?

Opportunity

40 / 100

Complexity

30 / 100

Risk factors

The procedure is explicitly not a procurement under EU/German procurement law. Legal remedies are via social courts, wh...

No estimated value, no volume guarantees. Discount agreements may be unattractive if volumes are low.

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • Supplies contract
  • 1 lot
  • Duration until Jun 2027
  • Supply of Agalsidase beta to the participating health insurance funds under discount agreements.
  • Open House procedure with no exclusivity and no negotiation.
Show full summary

This is an Open House procedure for Rabattverträge (discount agreements) under §130a SGB V for the active ingredient Agalsidase beta. The lead buyer is Techniker Krankenkasse (TK) in cooperation with HEK and hkk. The contract is a non-exclusive framework without negotiation; no estimated value is provided. The deadline for submission is 2027-06-29, but contributions are possible at any time during the contract period (01.07.2025-30.06.2027). Only one lot is identified. The opportunity is open to all qualified pharmaceutical entrepreneurs who meet the eligibility criteria. The notice explicitly states this is not a public procurement subject to procurement law, and legal challenges go to social courts. No procurement documents were analyzed (only the XML notice).

Risks

The procedure is explicitly not a procurement under EU/German procurement law. Legal remedies are via social courts, wh...

No estimated value, no volume guarantees. Discount agreements may be unattractive if volumes are low.

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • Must be a pharmaceutical entrepreneur within the meaning of §4(18) AMG with a valid marketing authorization for Agalsidase beta.
  • Registered seat in Germany, EU, or EEA (§9(2) AMG).

Eligibility

  • No criminal convictions or exclusion grounds (GWB §§123,124).

Requirements may be incomplete.

Award Criteria

Lot 1

No award criteria specified; contract is offered to all eligible participants without competitive award.

Buyer

Location

Hamburg, DEU

Identifier

992-80116-93

Activity

Health

Lots (1)

LOT-0001

Open-House-Biologika-Rabattverträge 2025-17 - Agalsidase beta

Conclusion of pharmaceutical discount agreements for the active substance Agalsidase beta under the Open House procedure. No exclusivity, no negotiation, uniform conditions. Contract term 24 months (01.07.2025-30.06.2027).

SuppliesEU fundedElectronic submission

Location

DE600, Germany

Duration

Jun 2025 - Jun 2027

Category

Pharmaceutical products

Award Criteria

No award criteria specified; contract is offered to all eligible participants without competitive award.

Deadline

Deadline Jun 29, 2027

Procurement Details

Publication date
25 May 2025
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
336062-2025

Documents (1)

Procurement document 1

Similar tenders

Germany – Site preparation work – VE111 Baustelleneinrichtung (119VM514 / Kronsh,SanDstBw,Ersatzneub. ZInstSanBw)

Sep 15
1 SME lot

Poland – Advertising and marketing services – Zaplanowanie i realizacja kampanii Ministerstwa Finansów z zakresu działalności resortu finansów

Sep 17

France – Insurance services – Prestations de services d'assurance pour groupement le groupement hospitalier de territoire Yvelines Nord

Sep 14
6 SME lots

Finland – Architectural, construction, engineering and inspection services – Tietomallikoordinaattori-, inventointimittaus- ja mallinnuspalvelujen puitejärjestely 2026-2028 (2028-2030)

Aug 27
3 framework lots3 SME lots

Greece – Cultural event organisation services – ΛΕΙΤΟΥΡΓΙΑ ΤΟΥ ΘΕΑΤΡΟΥ ΟΛΥΜΠΙΑ ΜΑΡΙΑ ΚΑΛΛΑΣ ΜΕ ΕΞΕΙΔΙΚΕΥΜΕΝΟ ΠΡΟΣΩΠΙΚΟ

Sep 18

Spain – Architectural, construction, engineering and inspection services – Redacción del Proyecto Básico y de Ejecución, Redacción del Estudio de Seguridad y Salud y Dirección de Obra para la construcción del I.E.S. Nº 1 de 12+0 uds. (Fase 1) en la urbanización El Bosque de Pioz (Guadalajara).

Sep 24